دورية أكاديمية
أعرض في EDS

Impact of concomitant COVID-19 on the outcome of patients with acute myocardial infarction undergoing coronary artery angiography.

التفاصيل البيبلوغرافية
العنوان: Impact of concomitant COVID-19 on the outcome of patients with acute myocardial infarction undergoing coronary artery angiography.
المؤلفون: Terlecki M; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Wojciechowska W; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Klocek M; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Olszanecka A; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Bednarski A; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Drożdż T; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Pavlinec C; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Lis P; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Zając M; Student's Scientific Group in the First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Rusinek J; Student's Scientific Group in the First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland., Siudak Z; Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland., Bartuś S; Second Department of Cardiology, Jagiellonian University Medical College, Kraków, Poland., Rajzer M; First Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland.
المصدر: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Sep 22; Vol. 9, pp. 917250. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne : Frontiers Media S.A., [2014]-
مستخلص: Background: The impact of COVID-19 on the outcome of patients with MI has not been studied widely. We aimed to evaluate the relationship between concomitant COVID-19 and the clinical course of patients admitted due to acute myocardial infarction (MI).
Methods: There was a comparison of retrospective data between patients with MI who were qualified for coronary angiography with concomitant COVID-19 and control group of patients treated for MI in the preceding year before the onset of the pandemic. In-hospital clinical data and the incidence of death from any cause on 30 days were obtained.
Results: Data of 39 MI patients with concomitant COVID-19 (COVID-19 MI) and 196 MI patients without COVID-19 in pre-pandemic era (non-COVID-19 MI) were assessed. Compared with non-COVID-19 MI, COVID-19 MI was in a more severe clinical state on admission (lower systolic blood pressure: 128.51 ± 19.76 vs. 141.11 ± 32.47 mmHg, p = 0.024), higher: respiratory rate [median (interquartile range), 16 (14-18) vs. 12 (12-14)/min, p < 0.001], GRACE score (178.50 ± 46.46 vs. 161.23 ± 49.74, p = 0.041), percentage of prolonged (>24 h) time since MI symptoms onset to coronary intervention (35.9 vs. 15.3%; p = 0.004), and cardiovascular drugs were prescribed less frequently (beta-blockers: 64.1 vs. 92.8%, p = 0.009), angiotensin-converting enzyme inhibitors/angiotensin receptor blockers: 61.5 vs. 81.1%, p < 0.001, statins: 71.8 vs. 94.4%, p < 0.001). Concomitant COVID-19 was associated with seven-fold increased risk of 30-day mortality (HR 7.117; 95% CI: 2.79-18.14; p < 0.001).
Conclusion: Patients admitted due to MI with COVID-19 have an increased 30-day mortality. Efforts should be focused on infection prevention and implementation of optimal management to improve the outcomes in those patients.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2022 Terlecki, Wojciechowska, Klocek, Olszanecka, Bednarski, Drożdż, Pavlinec, Lis, Zając, Rusinek, Siudak, Bartuś and Rajzer.)
References: Am J Cardiol. 2020 Sep 15;131:1-6. (PMID: 32732010)
Cardiovasc Res. 2021 Dec 17;117(14):2705-2729. (PMID: 34528075)
N Engl J Med. 2020 Jun 18;382(25):2478-2480. (PMID: 32302081)
Eur J Heart Fail. 2020 Jun;22(6):957-966. (PMID: 32412156)
Eur Heart J. 2007 May;28(10):1205-10. (PMID: 17440221)
Ann Intern Med. 2006 Aug 15;145(4):247-54. (PMID: 16908915)
Circulation. 1987 Jul;76(1):142-54. (PMID: 3109764)
Lancet. 2015 Mar 21;385(9973):1114-22. (PMID: 25467573)
Infect Drug Resist. 2021 Mar 05;14:895-903. (PMID: 33707958)
Front Cell Dev Biol. 2022 Feb 15;10:824851. (PMID: 35242762)
J Am Coll Cardiol. 2020 Nov 17;76(20):2321-2330. (PMID: 33183506)
Catheter Cardiovasc Interv. 2020 Nov;96(6):E568-E575. (PMID: 32686899)
Ann Lab Med. 2020 Mar 31;40(5):351-360. (PMID: 32237288)
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E319-E326. (PMID: 32667726)
Pol Arch Intern Med. 2020 Jun 25;130(6):557-558. (PMID: 32529822)
J Am Coll Cardiol. 2021 May 25;77(20):2466-2476. (PMID: 34016259)
Pol Arch Intern Med. 2022 Aug 22;132(7-8):. (PMID: 35522239)
Eur Heart J. 2018 Apr 1;39(13):1065-1074. (PMID: 29452351)
Heart. 2020 Oct;106(19):1512-1518. (PMID: 32817312)
Eur Heart J. 2018 Jan 7;39(2):119-177. (PMID: 28886621)
N Engl J Med. 2018 Jan 25;378(4):345-353. (PMID: 29365305)
Eur Heart J. 2016 Aug 1;37(29):2315-2381. (PMID: 27222591)
Postgrad Med J. 2020 Jul;96(1137):387-391. (PMID: 32434874)
Hypertension. 2020 Oct;76(4):1104-1112. (PMID: 32673499)
J Am Coll Cardiol. 2021 Apr 27;77(16):1994-2003. (PMID: 33888249)
Front Immunol. 2020 Oct 22;11:570681. (PMID: 33193350)
Lancet Infect Dis. 2020 May;20(5):533-534. (PMID: 32087114)
Kardiol Pol. 2021;79(7-8):773-780. (PMID: 33926173)
Front Cardiovasc Med. 2022 Mar 14;9:831143. (PMID: 35360030)
Eur Heart J. 2021 Apr 7;42(14):1289-1367. (PMID: 32860058)
JAMA. 2021 Jan 12;325(2):123-124. (PMID: 33331845)
JAMA. 2010 Aug 18;304(7):763-71. (PMID: 20716739)
Circ Cardiovasc Interv. 2020 Jul;13(7):e009438. (PMID: 32600109)
Front Cardiovasc Med. 2022 May 02;9:850447. (PMID: 35586652)
Life Sci. 2020 Jul 15;253:117723. (PMID: 32360126)
BMJ. 2006 Nov 25;333(7578):1091. (PMID: 17032691)
Pol Arch Intern Med. 2020 Apr 30;130(4):352-357. (PMID: 32231173)
JAMA Cardiol. 2020 Jul 1;5(7):831-840. (PMID: 32219363)
Adv Exp Med Biol. 2020;1251:115-121. (PMID: 31989546)
فهرسة مساهمة: Keywords: COVID-19; comorbidity; myocardial infarction; novel coronavirus; revascularization
تواريخ الأحداث: Date Created: 20221010 Latest Revision: 20221011
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9536466
DOI: 10.3389/fcvm.2022.917250
PMID: 36211554
قاعدة البيانات: MEDLINE
الوصف
تدمد:2297-055X
DOI:10.3389/fcvm.2022.917250